Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v3-EN Version v2-FR
Language English French
Date Updated 2023-04-02 2023-02-06
Drug Identification Number 02485451 02485451
Brand name CLINDAMYCIN INJECTION IN 5% DEXTROSE CLINDAMYCIN INJECTION IN 5% DEXTROSE
Common or Proper name CLINDAMYCIN INJECTION IN 5% DEXTROSE (300mg/50mL) CLINDAMYCIN INJECTION IN 5% DEXTROSE (300mg/50mL)
Company Name BAXTER CORPORATION BAXTER CORPORATION
Ingredients CLINDAMYCIN CLINDAMYCIN
Strength(s) 300MG 300MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS INTRAVENOUS INTRAVENOUS
Packaging size 50ml 50ml
ATC code J01FF J01FF
ATC description MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date 2023-04-01 2023-04-01
Actual discontinuation date 2023-04-01 2023-04-01
Remaining supply date 2023-04-01 2023-04-01
Discontinuation status Discontinued To be discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments
Health Canada comments